Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2011; 17(37): 4218-4224
Published online Oct 7, 2011. doi: 10.3748/wjg.v17.i37.4218
Published online Oct 7, 2011. doi: 10.3748/wjg.v17.i37.4218
Table 1 Patient characteristics
Gender | |
Female | 52 |
Male | 65 |
Age (mean), yr | 3.23 (3 mo-10 yr) |
Pathogen identified | |
Rotavirus | 41 |
Norovirus | 28 |
Salmonella | 31 |
Campylobacter | 17 |
Disease severity (Vesikari scoring scale) | |
Mild | 42 |
Moderate | 50 |
Severe | 25 |
Duration of diarrhea (median), h | 73.8 (14-169) |
Vomiting, (d) | 2.1 (0-5) |
Fever, (d) | 2.9 (0-7) |
WBC counts (106/L) | 12 658 ± 2364 |
CRP (mg/L) | 34.7 ± 22.1 |
Hemoglobin (g/dL, n = 117) | 11.6 (8.2-15.3) |
Platelets (109/L, n = 117) | 232 (134-585) |
Table 2 The Vesikari and Clark severity scoring scales for the evaluation of gastroenteritis in children
Severity scoring scales | Point value | ||
1 | 2 | 3 | |
Vesikari[5] | |||
Duration of diarrhea (d) | 1-4 | 5 | ≥ 6 |
Maximum number of diarrhea stools/24 h | 1-3 | 4-5 | ≥ 6 |
Duration of vomiting (d) | 1 | 2 | ≥ 3 |
Maximum number of vomiting episodes/24 h | 1 | 2-4 | ≥ 5 |
Temperature (°C) | 37.1-38.4 | 38.5-38.9 | ≥ 39.0 |
Dehydration | - | Mild | Moderate to severe |
Treatment | Rehydration | Hospitalization | - |
Clark[6] | |||
Diarrhea | |||
Number of stools/d | 2-4 | 5-7 | ≥ 8 |
Duration in days | 1-4 | 5-7 | ≥ 8 |
Vomiting | |||
Number of emeses/d | 1-3 | 4-6 | ≥ 7 |
Duration in days | 2 | 3-5 | ≥ 6 |
Rectal temperature | |||
Temperature (°C) | 38.1-38.2 | 38.3-38.7 | ≥ 38.8 |
Duration in days | 1-2 | 3-4 | ≥ 5 |
Behavioral symptoms/signs | |||
Description | Irritable/less playful | Lethargic/listless | Seizure |
Duration in days | 1-2 | 3-4 | ≥ 5 |
Table 3 Univariate linear regression outcome: Lactoferrin (y = α + βx)
β | Standard error | 95% CI | P value | ||
Lower | Upper | ||||
WBC | -0.05 | 0.10 | -0.25 | 0.14 | 0.581 |
Segment | 0.00 | 0.02 | -0.05 | 0.05 | 0.941 |
Band | 0.47 | 0.27 | -0.07 | 1.01 | 0.089 |
CRP | 0.02 | 0.01 | 0.00 | 0.04 | 0.043a |
Fecal pus cell | |||||
None | 0.00 | ||||
Present | 0.38 | 1.55 | -2.74 | 3.49 | 0.809 |
Fecal occult blood | |||||
None | 0.00 | ||||
Present | 1.71 | 1.22 | -0.73 | 4.15 | 0.165 |
Fecal mucus | |||||
None | 0.00 | ||||
Positive | -2.21 | 1.46 | -5.14 | 0.71 | 0.135 |
Vesikari scoring scale | |||||
Non-severe < 11 | 0.00 | ||||
Moderate ≥ 11 | 2.76 | -1.50 | 7.02 | 0.191 | |
Severe ≥ 16 | 2.81 | 1.13 | 0.56 | 5.07 | 0.015a |
Clark scoring scale | |||||
Non-severe < 16 | 0.00 | ||||
Severe ≥ 16 | 3.13 | 1.10 | 0.93 | 5.32 | 0.006a |
Body temperature | 0.29 | 0.30 | -0.31 | 0.89 | 0.341 |
Abdominal pain | 0.88 | 0.63 | -0.39 | 2.15 | 0.169 |
Abdominal distension | -0.30 | 1.01 | -2.32 | 1.71 | 0.764 |
Dehydration | 3.13 | 1.38 | 0.37 | 5.89 | 0.027a |
Oral intake | 1.13 | 1.23 | -1.33 | 3.59 | 0.362 |
Activity | 1.13 | 1.00 | -0.87 | 3.13 | 0.262 |
Fever day | 0.09 | 0.28 | -0.46 | 0.65 | 0.739 |
Diarrhea day | 0.41 | 0.29 | -0.60 | 1.41 | 0.423 |
Vomiting day | -0.99 | 0.53 | -1.93 | -0.04 | 0.041a |
Table 4 Generalized estimating equations analysis for series follow-up of fecal lactoferrin
Parameter | Estimate | Standarderror | 95% confidence interval | P value | |
Clark score | |||||
Intercept | 5.1523 | 0.7490 | 3.6843 | 6.6202 | < 0.0001a |
Clark score | 2.0393 | 1.7397 | -1.3704 | 5.4489 | 0.2411 |
Time | -0.3729 | 0.2530 | -0.8688 | 0.123 | 0.1405 |
Time x Clark | 0.5826 | 0.8342 | -1.0525 | 2.2177 | 0.485 |
Vesikari score | |||||
Intercept | 3.9289 | 0.8437 | 2.2752 | 5.5825 | < 0.0001a |
Vesikari score | 3.2257 | 1.3018 | 0.6741 | 5.7773 | 0.0132a |
Time | -0.1835 | 0.2715 | -0.7157 | 0.3487 | 0.4992 |
Time x Vesikari | -0.1575 | 0.5222 | -1.1811 | 0.8660 | 0.0429a |
Band (band form neutrophil) | |||||
Intercept | 3.6654 | 1.0750 | 1.5585 | 5.7723 | 0.0007a |
Band | 1.9759 | 0.6951 | 0.6135 | 3.3383 | 0.0045a |
Time | 1.6270 | 0.8206 | 0.0186 | 3.2354 | 0.0474a |
Band x time | -1.5261 | 0.4677 | -2.4428 | -0.6094 | 0.0011a |
- Citation: Chen CC, Chang CJ, Lin TY, Lai MW, Chao HC, Kong MS. Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea. World J Gastroenterol 2011; 17(37): 4218-4224
- URL: https://www.wjgnet.com/1007-9327/full/v17/i37/4218.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i37.4218